KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Treasury Shares (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Treasury Shares data on record, last reported at $7.1 billion in Q4 2025.

  • For Q4 2025, Treasury Shares rose 14.52% year-over-year to $7.1 billion; the TTM value through Dec 2025 reached $7.1 billion, up 14.52%, while the annual FY2025 figure was $7.1 billion, 14.52% up from the prior year.
  • Treasury Shares reached $78.0 million in Q4 2025 per EW's latest filing, up from $6.3 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $78.0 million in Q4 2025 and bottomed at -$1.3 million in Q2 2021.
  • Average Treasury Shares over 5 years is $36.1 million, with a median of $39.6 million recorded in 2022.
  • Peak YoY movement for Treasury Shares: skyrocketed 71.46% in 2022, then rose 14.37% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $2.4 billion in 2021, then surged by 71.46% to $4.1 billion in 2022, then grew by 21.25% to $5.0 billion in 2023, then grew by 23.24% to $6.2 billion in 2024, then rose by 14.52% to $7.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $7.1 billion in Q4 2025, $7.0 billion in Q3 2025, and $6.5 billion in Q2 2025.